256 Newsroom — Uganda's Digital News Infrastructure
Business

Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors - Endpoints News

Share
Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors - Endpoints News
Image · Endpoints.news

What the report says

Lilly's 13 acquisitions in 2026, worth about $32B, are recycling cash back to at least 50 biotech venture investors.

Read the full report at Endpoints.news →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting